| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.UROLOGY.2012.01.047 |
| P698 | PubMed publication ID | 22521193 |
| P2093 | author name string | Hann-Chorng Kuo | |
| Hsin-Tzu Liu | |||
| Sung-Ho Chen | |||
| Yu-Syuan Wang | |||
| Jia-Heng Shie | |||
| P2860 | cites work | Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium | Q28255146 |
| Myofibroblasts. II. Intestinal subepithelial myofibroblasts | Q33709887 | ||
| Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. | Q33728157 | ||
| Characterization of tight junction proteins in cultured human urothelial cells | Q33762578 | ||
| Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis | Q33904356 | ||
| The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis | Q34623214 | ||
| Role of urothelial nerve growth factor in human bladder function | Q34939500 | ||
| Differentiation potential of urothelium from patients with benign bladder dysfunction | Q35966453 | ||
| Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis | Q36628753 | ||
| Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis | Q37121156 | ||
| Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome | Q37250416 | ||
| The mechanoreceptor TRPV4 is localized in adherence junctions of the human bladder urothelium: a morphological study. | Q39501791 | ||
| Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis | Q40396295 | ||
| Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity | Q43277066 | ||
| Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. | Q43644818 | ||
| Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome | Q44785160 | ||
| Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. | Q45971212 | ||
| Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection | Q46601229 | ||
| Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder | Q46635583 | ||
| Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. | Q46644837 | ||
| Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. | Q47960362 | ||
| Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. | Q51368501 | ||
| Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis | Q73286098 | ||
| Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis | Q81465646 | ||
| Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome | Q82934024 | ||
| Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder | Q83337237 | ||
| The therapeutic challenge of "chronic cystitis": search well, work together, and gain results | Q83807686 | ||
| Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study | Q84590969 | ||
| P433 | issue | 1 | |
| P921 | main subject | mast cell | Q191989 |
| P304 | page(s) | 225.e13-8 | |
| P577 | publication date | 2012-04-21 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome | |
| P478 | volume | 80 |
| Q56772774 | Q56772774 |
| Q36262124 | Beta-3 adrenergic receptors could be significant factors for overactive bladder-related symptoms |
| Q26750535 | Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action |
| Q36912832 | Changes in mast cell infiltration: a possible mechanism in detrusor overactivity induced by visceral hypersensitivity |
| Q38086764 | Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome |
| Q89578185 | Effect of Botulinum Toxin A on Bladder Pain-Molecular Evidence and Animal Studies |
| Q55345274 | Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition. |
| Q64054760 | Histamine modulation of urinary bladder urothelium, lamina propria and detrusor contractile activity via H1 and H2 receptors |
| Q34730943 | Increased urothelial cell apoptosis and chronic inflammation are associated with recurrent urinary tract infection in women |
| Q36382104 | Increased urothelial paracellular transport promotes cystitis |
| Q37337587 | Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C |
| Q36404141 | Mast Cell-Mediated Mechanisms of Nociception |
| Q41680745 | Mast cells infiltration and decreased E-cadherin expression in ketamine-induced cystitis |
| Q60958347 | Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome |
| Q91900744 | Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome |
| Q28079052 | Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease |
| Q53445626 | Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions. |
| Q36085579 | Prevalence of overlap syndromes and symptoms in pediatric functional dyspepsia |
| Q31143378 | Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan |
| Q59341080 | Recent advances in imaging and understanding interstitial cystitis |
| Q26773584 | Sympathetic nervous system and chronic bladder pain: a new tune for an old song |
| Q64066628 | The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study |
| Q35933212 | The human urothelial tight junction: claudin 3 and the ZO-1α(+) switch |
| Q93145668 | Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency |
| Q37071490 | Tissue-engineered tubular substitutions for urinary diversion in a rabbit model |
| Q48132173 | Urothelial Dysfunction and Chronic Inflammation are Associated With Increased Bladder Sensation in Patients With Chronic Renal Insufficiency. |
| Q34374493 | Urothelial dysfunction and increased suburothelial inflammation of urinary bladder are involved in patients with upper urinary tract urolithiasis--clinical and immunohistochemistry study |
| Q37654718 | Vaginal hypersensitivity and hypothalamic-pituitary-adrenal axis dysfunction as a result of neonatal maternal separation in female mice. |
Search more.